Ocugen (OCGN) Short Interest Ratio & Short Volume $0.74 -0.05 (-6.37%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$0.74 +0.00 (+0.58%) As of 10/23/2026 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Ocugen Short Interest OverviewAs of September 30, 2026, Ocugen (OCGN) had a short interest of 102.05 million shares sold short, representing 31.33% of the public float. This marks a -3.78% decrease in short interest since the prior report. The short interest ratio (days to cover) is 13.7, meaning it would take 13.7 days of the average trading volume of 6.56 million shares to cover all short positions.Current Short Interest102,053,118 sharesPrevious Short Interest106,062,298 sharesChange Vs. Previous Month-3.78%Dollar Volume Sold Short$105.11 millionShort Interest Ratio13.7 Days to CoverLast Record DateSeptember 30, 2026Outstanding Shares339,110,000 sharesShort Percent of Float31.33%Today's Trading Volume8,577,628 sharesAverage Trading Volume6,562,989 sharesToday's Volume Vs. Average131% Short Selling Ocugen? Sign up to receive the latest short interest report for Ocugen and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOCGN Short Interest Over TimeOCGN Days to Cover Over TimeOCGN Percentage of Float Shorted Over Time Ocugen Tesla Short Interest History & Recent Changes ExportReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/2026102,053,118 shares $105.11 million -3.8%31.3%13.66 $1.03 9/15/2026106,062,298 shares $105.00 million +7.9%32.6%10.39 $0.99 8/31/202698,309,421 shares $130.75 million -3.4%30.2%28.24 $1.33 8/14/2026101,770,376 shares $137.39 million +0.9%31.2%23.89 $1.35 7/31/2026100,913,607 shares $124.12 million +0.3%31.0%21.55 $1.23 7/15/2026100,590,405 shares $143.84 million -4.6%30.9%18.85 $1.43 6/30/2026105,430,735 shares $161.31 million +21.8%32.4%7.07 $1.53 6/15/202686,561,503 shares $105.61 million +4.3%26.6%18.49 $1.22 5/29/202683,020,405 shares $114.57 million +2.4%25.5%14.32 $1.38 5/15/202681,047,338 shares $112.66 million +16.3%24.9%8.16 $1.39 Get the Latest News and Ratings for OCGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocugen and its competitors with MarketBeat's FREE daily newsletter. 4/30/202669,673,506 shares $120.54 million +2.6%21.4%11.56 $1.73 4/15/202667,890,507 shares $132.39 million +4.8%20.9%12.42 $1.95 3/31/202664,754,908 shares $117.21 million +23.7%19.9%5.29 $1.81 3/13/202652,358,943 shares $129.85 million +3.5%16.7%4.18 $2.48 2/27/202650,589,268 shares $92.07 million +3.1%16.1%9.93 $1.82 2/13/202649,061,740 shares $69.18 million +3.8%15.1%14.96 $1.41 1/30/202647,284,982 shares $68.56 million -1.3%15.8%8.49 $1.45 1/15/202647,899,156 shares $77.60 million +3.3%16.0%6.69 $1.62 12/31/202546,392,427 shares $62.63 million -21.4%15.5%11.37 $1.35 12/15/202558,994,853 shares $81.41 million -0.8%19.7%17.14 $1.38 11/28/202559,490,622 shares $82.10 million +0.7%19.9%20.54 $1.38 11/14/202559,091,529 shares $70.32 million +1.9%21.2%15.61 $1.19 10/31/202558,010,350 shares $90.50 million -0.2%20.8%17.62 $1.56 10/15/202558,100,000 shares $97.03 million +10.1%20.8%13.2 $1.67 9/30/202552,780,000 shares $86.03 million -2.4%N/A12.6 $1.63 9/15/202554,080,000 shares $64.90 million -0.8%N/A12 $1.20 8/31/202554,540,000 shares $55.63 million -1.2%19.5%12.7 $1.02 8/15/202555,220,000 shares $57.98 million +0.8%N/A11 $1.05 7/31/202554,760,000 shares $56.40 million -2.4%19.6%9.9 $1.03 7/15/202556,130,000 shares $60.06 million -11.2%N/A10.1 $1.07 6/30/202563,210,000 shares $61.34 million -3.0%22.6%11.3 $0.97 6/15/202565,190,000 shares $73.66 million -4.8%23.4%13.7 $1.13 5/31/202568,470,000 shares $57.81 million -1.6%24.6%15.8 $0.84 5/15/202569,600,000 shares $49.37 million +2.0%25.0%17 $0.71 4/30/202568,230,000 shares $50.98 million -0.6%N/A18.1 $0.75 4/15/202568,670,000 shares $47.99 million +4.4%24.6%18.1 $0.70 3/31/202565,790,000 shares $46.71 million -2.6%23.6%16.3 $0.71 3/15/202567,510,000 shares $36.27 million +6.0%24.2%14.7 $0.54 2/28/202563,670,000 shares $41.49 million +5.7%22.8%13.7 $0.65 2/15/202560,260,000 shares $43.26 million +2.3%21.6%13.4 $0.72You haven't downloaded this yet (Ad)Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarter he swaps in a brand-new list, and once the new edition launches, this one disappears. Investors who want a current snapshot of his picks should grab a copy now and save it before the switch happens.Download your free copy before the new quarter's list replaces it 1/31/202558,880,000 shares $42.83 million +4.9%N/A12.4 $0.73 1/15/202556,110,000 shares $40.90 million +7.4%N/A11.8 $0.73 12/31/202452,260,000 shares $42.07 million -10.9%N/A11.9 $0.81 12/15/202458,630,000 shares $50.27 million +2.9%N/A14 $0.86 11/30/202457,000,000 shares $55.97 million +4.8%N/A15.5 $0.98 11/15/202454,400,000 shares $51.06 million +7.4%N/A15 $0.94 10/31/202450,650,000 shares $46.14 million -2.5%N/A14.2 $0.91 10/15/202451,920,000 shares $49.17 million +2.6%N/A13.2 $0.95 9/30/202450,620,000 shares $50.23 million -0.6%N/A11.9 $0.99 9/15/202450,900,000 shares $61.59 million -0.6%N/A9.7 $1.21 8/31/202451,230,000 shares $66.60 million -0.1%N/A9.5 $1.30 8/15/202451,270,000 shares $67.16 million -19.9%N/A9.2 $1.31 7/31/202464,030,000 shares $89.96 million +4.1%N/A10.1 $1.41 7/15/202461,520,000 shares $117.50 million +15.8%N/A9.6 $1.91 6/30/202453,120,000 shares $82.34 million +8.3%N/A7.6 $1.55 6/15/202449,060,000 shares $69.67 million +1.6%N/A5.9 $1.42 5/31/202448,310,000 shares $83.58 million -7.2%N/A5.6 $1.73 5/15/202452,080,000 shares $102.08 million +8.8%N/A5.7 $1.96 4/30/202447,890,000 shares $63.21 million +5.9%N/A4.9 $1.32 4/15/202445,230,000 shares $71.92 million +4.0%N/A5 $1.59 3/31/202443,480,000 shares $71.31 million +22.8%N/A5.3 $1.64 3/15/202435,400,000 shares $38.23 million -3.4%N/A4.5 $1.08 2/29/202436,650,000 shares $34.30 million +50.5%N/A6.7 $0.94 2/15/202424,360,000 shares $18.17 million +2.7%N/A5 $0.75 1/31/202423,710,000 shares $12.71 million -8.6%N/A9.3 $0.54 1/15/202425,950,000 shares $15.53 million +10.4%N/A10.2 $0.60 12/31/202323,510,000 shares $13.52 million +5.6%N/A9.6 $0.58 12/15/202322,270,000 shares $8.41 million -6.5%N/A12.3 $0.38 11/30/202323,820,000 shares $9.21 million -5.4%N/A17.3 $0.39 11/15/202325,180,000 shares $9.56 million +2.0%N/A16.6 $0.38 10/31/202324,690,000 shares $9.08 million -2.6%N/A11.7 $0.37 10/15/202325,360,000 shares $10.61 million +0.6%N/A10 $0.42 9/30/202325,220,000 shares $10.09 million +3.7%N/A7.9 $0.40 9/15/202324,330,000 shares $9.96 million -4.7%N/A5.6 $0.41 8/31/202325,520,000 shares $11.00 million +3.4%N/A4.7 $0.43 8/15/202324,680,000 shares $11.76 million -0.6%N/A3.4 $0.48 7/31/202324,830,000 shares $15.27 million -2.3%N/A3.3 $0.62 7/15/202325,410,000 shares $14.83 million -5.7%N/A3.2 $0.58 6/30/202326,940,000 shares $14.63 million -27.7%N/A3.5 $0.54 6/15/202337,250,000 shares $19.99 million -10.9%N/A5 $0.54 5/31/202341,790,000 shares $19.22 million +2.5%N/A5.6 $0.46 5/15/202340,760,000 shares $29.92 million +2.0%N/A6.2 $0.73 4/30/202339,950,000 shares $28.51 million +6.4%N/A6.4 $0.71 4/15/202337,540,000 shares $30.04 million +1.2%N/A6.1 $0.80 3/31/202337,100,000 shares $31.65 million -27.1%N/A5.5 $0.85 3/15/202350,880,000 shares $46.88 million +2.9%N/A7.5 $0.92 2/28/202349,470,000 shares $49.28 million +4.4%N/A8.6 $1.00 2/15/202347,390,000 shares $52.13 million +5.4%N/A9 $1.10 1/31/202344,970,000 shares $57.11 million +0.9%N/A8.6 $1.27 1/15/202344,590,000 shares $57.97 million +9.7%N/A8.8 $1.30Why tech stocks are dead (Ad)AI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers. Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever. Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7.Watch Porter Stansberry's broadcast to see which sector could lead next 12/30/202240,650,000 shares $52.85 million +0.3%N/A8.3 $1.30 12/15/202240,530,000 shares $58.77 million +0.5%N/A8.8 $1.45 11/30/202240,350,000 shares $62.95 million -2.8%N/A8.6 $1.56 11/15/202241,530,000 shares $71.43 million -4.0%N/A8.6 $1.72 10/31/202243,270,000 shares $74.42 million +0.1%N/A8.6 $1.72 10/15/202243,210,000 shares $67.41 million -1.3%N/A8.6 $1.56 9/30/202243,790,000 shares $77.95 million +6.6%N/A8.5 $1.78 9/15/202241,080,000 shares $96.95 million -9.4%N/A7.8 $2.36 8/31/202245,340,000 shares $116.98 million -7.6%N/A8.1 $2.58 8/15/202249,070,000 shares $141.32 million -11.9%N/A8.2 $2.88 7/31/202255,700,000 shares $143.71 million +3.3%N/A8.7 $2.58 7/15/202253,940,000 shares $139.17 million -1.1%N/A8.1 $2.58 6/30/202254,540,000 shares $123.81 million -0.3%N/A7.8 $2.27 6/15/202254,690,000 shares $113.76 million -8.4%N/A7.6 $2.08 5/31/202259,720,000 shares $141.54 million +3.2%N/A7.2 $2.37 5/15/202257,850,000 shares $121.49 million -1.3%N/A5.3 $2.10 4/30/202258,600,000 shares $128.33 million +8.7%N/A5.5 $2.19 4/15/202253,910,000 shares $148.79 million -2.4%N/A4.7 $2.76 3/31/202255,230,000 shares $182.26 million +14.7%N/A4.5 $3.30 3/15/202248,140,000 shares $130.46 million -6.1%N/A3.6 $2.71 2/28/202251,290,000 shares $180.54 million -5.9%N/A3.7 $3.52 2/15/202254,510,000 shares $212.59 million -0.8%N/A3.9 $3.90 1/31/202254,940,000 shares $195.04 million +1.2%30.2%3.8 $3.55 1/15/202254,310,000 shares $230.82 million -1.7%27.9%1.9 $4.25 12/31/202155,220,000 shares $251.25 million +1.7%28.4%1.7 $4.55 12/15/202154,300,000 shares $294.31 million +9.8%27.8%1.6 $5.42 11/30/202149,470,000 shares $313.64 million +5.4%25.3%1.5 $6.34 11/15/202146,930,000 shares $389.52 million -14.3%24.1%1.5 $8.30 10/29/202154,770,000 shares $648.48 million -3.9%28.2%1.8 $11.84 OCGN Short Interest - Frequently Asked Questions What is Ocugen's current short interest? Short interest is the volume of Ocugen shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 102,053,118 shares of OCGN short. 31.33% of Ocugen's shares are currently sold short. Learn More on Ocugen's current short interest. What is a good short interest ratio for Ocugen? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCGN shares currently have a short interest ratio of 13.7. Learn More on Ocugen's short interest ratio. What is a good short interest percentage for Ocugen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 31.33% of Ocugen's floating shares are currently sold short. Is Ocugen's short interest increasing or decreasing? Ocugen saw a decrease in short interest during the month of September. As of September 30th, there was short interest totaling 102,053,118 shares, a decrease of 3.8% from the previous total of 106,062,298 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ocugen's short interest compare to its competitors? 31.33% of Ocugen's shares are currently sold short. Here is how the short interest of companies in the sector of "healthcare" compare to Ocugen: Moderna, Inc. (8.67%), Pfizer Inc. (2.65%), Replimune Group, Inc. (26.06%), Oric Pharmaceuticals, Inc. (16.69%), Nanobiotix S.A. - Sponsored ADR (0.30%), Tyra Biosciences, Inc. (18.03%), Vor Biopharma Inc. (13.24%), Bicara Therapeutics Inc. (18.75%), First Tracks Biotherapeutics (14.53%), Janux Therapeutics, Inc. (10.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.10 billion), Invesco QQQ ($52.12 billion), iShares Russell 2000 ETF ($25.28 billion), SPDR S&P Biotech ETF ($11.70 billion), Nebius Group N.V. ($10.54 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($9.69 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.22 billion), iShares 20+ Year Treasury Bond ETF ($8.80 billion), Financial Select Sector SPDR Fund ($7.65 billion), and Lumentum Holdings Inc. ($7.23 billion). View all of the most shorted stocks. What does it mean to sell short Ocugen stock? Short selling OCGN is an investing strategy that aims to generate trading profit from Ocugen as its price is falling. OCGN shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ocugen? A short squeeze for Ocugen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OCGN, which in turn drives the price of the stock up even further. How often is Ocugen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCGN, twice per month. The most recent reporting period available is September, 30 2026. What do OCGN's short interest metrics mean? Understanding short interest metrics can help you assess how traders are positioning around a stock like OCGN:Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity. More Short Interest Resources from MarketBeat Related Companies MRNA Short Interest Data PFE Short Interest Data REPL Short Interest Data ORIC Short Interest Data NBTX Short Interest Data TYRA Short Interest Data VOR Short Interest Data BCAX Short Interest Data TRAX Short Interest Data JANX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates Short interest data for NASDAQ:OCGN is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/9/2026. FINRA publishes updated short interest twice a month. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the b...Porter & Company | SponsoredYou haven't downloaded this yetBill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...Profits Run | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredMissed this in 2024? Here’s your second chanceIn April 2024, gold had gone nowhere for 13 years - then it surged to a record high, more than doubling in val...Traders Agency | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocugen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocugen With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
